Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.
Malignant pleural mesothelioma (MPM) is a poor prognosis disease lacking adequate therapy. We have previously shown that ascorbic acid administration is toxic to MPM cells. Here we evaluated a new combined therapy consisting of ascorbate/epigallocatechin-3-gallate/gemcitabine mixture (called AND, fo...
Main Authors: | Viviana Volta, Elia Ranzato, Simona Martinotti, Simone Gallo, Maria Veronica Russo, Luciano Mutti, Stefano Biffo, Bruno Burlando |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3590277?pdf=render |
Similar Items
-
Targeting Calcium Signalling in Malignant Mesothelioma
by: Simona Martinotti, et al.
Published: (2019-11-01) -
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
by: Dario P. Anobile, et al.
Published: (2021-05-01) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
by: Federica Morani, et al.
Published: (2021-03-01) -
Honey exposure stimulates wound repair of human dermal fibroblasts
by: Elia Ranzato, et al.
Published: (2013-07-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)